These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 31330313)

  • 1. Diabetes drugs in the fight against Alzheimer's disease.
    Boccardi V; Murasecco I; Mecocci P
    Ageing Res Rev; 2019 Sep; 54():100936. PubMed ID: 31330313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between Alzheimer's disease and diabetes: a focus on anti-diabetic drugs.
    Goodarzi G; Tehrani SS; Fana SE; Moradi-Sardareh H; Panahi G; Maniati M; Meshkani R
    Metab Brain Dis; 2023 Aug; 38(6):1769-1800. PubMed ID: 37335453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.
    Gupta A; Bisht B; Dey CS
    Neuropharmacology; 2011 May; 60(6):910-20. PubMed ID: 21277873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin in Alzheimer's disease: An overview of potential mechanisms, preclinical and clinical findings.
    Khezri MR; Yousefi K; Mahboubi N; Hodaei D; Ghasemnejad-Berenji M
    Biochem Pharmacol; 2022 Mar; 197():114945. PubMed ID: 35134385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment.
    Li X; Song D; Leng SX
    Clin Interv Aging; 2015; 10():549-60. PubMed ID: 25792818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term use of metformin and Alzheimer's disease: beneficial or detrimental effects.
    Al-Kuraishy HM; Al-Gareeb AI; Saad HM; Batiha GE
    Inflammopharmacology; 2023 Jun; 31(3):1107-1115. PubMed ID: 36849855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antidiabetic agents on Alzheimer's disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin.
    Ali SK; Ali RH
    PLoS One; 2022; 17(7):e0271138. PubMed ID: 35802659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SGLT2 and DPP4 inhibitors improve Alzheimer's disease-like pathology and cognitive function through distinct mechanisms in a T2D-AD mouse model.
    Sim AY; Choi DH; Kim JY; Kim ER; Goh AR; Lee YH; Lee JE
    Biomed Pharmacother; 2023 Dec; 168():115755. PubMed ID: 37871560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.
    Markowicz-Piasecka M; Sikora J; Szydłowska A; Skupień A; Mikiciuk-Olasik E; Huttunen KM
    Pharm Res; 2017 Dec; 34(12):2614-2627. PubMed ID: 28589443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin Facilitates Amyloid-β Generation by β- and γ-Secretases via Autophagy Activation.
    Son SM; Shin HJ; Byun J; Kook SY; Moon M; Chang YJ; Mook-Jung I
    J Alzheimers Dis; 2016; 51(4):1197-208. PubMed ID: 26967226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Hierro-Bujalance C; Ortegon E; Pickett E; Jackson R; Hernandez-Pacho F; Spires-Jones T; Garcia-Alloza M
    Mol Neurobiol; 2018 Jul; 55(7):6130-6144. PubMed ID: 29224179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease.
    Alagiakrishnan K; Sankaralingam S; Ghosh M; Mereu L; Senior P
    Discov Med; 2013 Dec; 16(90):277-86. PubMed ID: 24333407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic literature review of the effect of insulin sensitizers on the cognitive symptoms of Alzheimer's Disease in transgenic mice.
    Craig A; Parvez F; Issberner J
    Behav Brain Res; 2019 Oct; 372():112015. PubMed ID: 31255671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic insight into the role of metformin in Alzheimer's disease.
    Sanati M; Aminyavari S; Afshari AR; Sahebkar A
    Life Sci; 2022 Feb; 291():120299. PubMed ID: 34999113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus.
    Pelle MC; Zaffina I; Giofrè F; Pujia R; Arturi F
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidiabetic Drugs in the Treatment of Alzheimer's Disease.
    Michailidis M; Tata DA; Moraitou D; Kavvadas D; Karachrysafi S; Papamitsou T; Vareltzis P; Papaliagkas V
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidiabetic drugs for Alzheimer's and Parkinson's diseases: Repurposing insulin, metformin, and thiazolidinediones.
    Cardoso S; Moreira PI
    Int Rev Neurobiol; 2020; 155():37-64. PubMed ID: 32854858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of Metformin in Alzheimer's disease: A translational view.
    Ríos JA; Bórquez JC; Godoy JA; Zolezzi JM; Furrianca MC; Inestrosa NC
    Ageing Res Rev; 2024 Sep; 100():102439. PubMed ID: 39074563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glucagon-like peptide-1 (GLP-1) mimetics: a new treatment for Alzheimer's disease?].
    García-Casares N; García-Arnés JA; Gómez-Huelgas R; Valdivielso-Felices P; García-Arias C; González-Santos P
    Rev Neurol; 2014 Dec; 59(11):517-24. PubMed ID: 25418147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease.
    Nowell J; Blunt E; Gupta D; Edison P
    Ageing Res Rev; 2023 Aug; 89():101979. PubMed ID: 37328112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.